Literature DB >> 11072433

Pharmacodynamic effects of new de-nicotinized cigarettes.

W B Pickworth1, R V Fant, R A Nelson, M S Rohrer, J E Henningfield.   

Abstract

The effects of cigarette smoking result from the delivery of nicotine, other components of smoke, and sensory stimulation. In the present study, pharmacological effects of new tobacco-derived de-nicotinized cigarettes (controls) were compared with standard cigarettes. The de-nicotinized cigarettes had the appearance, draw and taste of standard cigarettes but contained and delivered virtually no nicotine (< 0.06 mg), but delivered tar and carbon monoxide (CO). They were compared with cigarettes that delivered nicotine, CO and tar. Subjects (n = 20: 10 men, 10 women) participated in four experimental sessions in which they smoked either a standard cigarette or a de-nicotinized cigarette after either 3 or 12 h of tobacco deprivation. Heart rate, blood pressure, and EEG were recorded before, and for 1 h after, ad lib smoking. Plasma nicotine concentrations verified that de-nicotinized cigarettes did not deliver nicotine. The de-nicotinized cigarettes did not increase heart rate or activate the EEG. The subjects preferred the cigarettes that delivered nicotine compared to the de-nicotinized cigarettes. However, both types of cigarettes reduced subjective measures of tobacco craving and withdrawal. These data extend previous research that suggested the process of smoking and components of tobacco smoke other than nicotine mediate some effects of cigarette smoking. The de-nicotinized cigarettes may prove useful in evaluating effects of smoking independent of the delivery of nicotine.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 11072433     DOI: 10.1080/14622299050011491

Source DB:  PubMed          Journal:  Nicotine Tob Res        ISSN: 1462-2203            Impact factor:   4.244


  55 in total

Review 1.  Nicotine reduction revisited: science and future directions.

Authors:  Dorothy K Hatsukami; Kenneth A Perkins; Mark G Lesage; David L Ashley; Jack E Henningfield; Neal L Benowitz; Cathy L Backinger; Mitch Zeller
Journal:  Tob Control       Date:  2010-10       Impact factor: 7.552

2.  Effects of cigarette smoking and abstinence on Stroop task performance.

Authors:  Catherine P Domier; John R Monterosso; Arthur L Brody; Sara L Simon; Adrianna Mendrek; Richard Olmstead; Murray E Jarvik; Mark S Cohen; Edythe D London
Journal:  Psychopharmacology (Berl)       Date:  2007-07-19       Impact factor: 4.530

3.  How Intravenous Nicotine Administration in Smokers Can Inform Tobacco Regulatory Science.

Authors:  Kevin P Jensen; Elise E DeVito; Mehmet Sofuoglu
Journal:  Tob Regul Sci       Date:  2016-10-01

4.  Reinforcing effects of nicotine and non-nicotine components of cigarette smoke.

Authors:  Jed E Rose; Al Salley; Frederique M Behm; James E Bates; Eric C Westman
Journal:  Psychopharmacology (Berl)       Date:  2010-04-01       Impact factor: 4.530

Review 5.  Nicotine and nonnicotine factors in cigarette addiction.

Authors:  Jed E Rose
Journal:  Psychopharmacology (Berl)       Date:  2005-12-16       Impact factor: 4.530

6.  Sex differences in acute relief of abstinence-induced withdrawal and negative affect due to nicotine content in cigarettes.

Authors:  Kenneth A Perkins; Joshua L Karelitz
Journal:  Nicotine Tob Res       Date:  2015-04       Impact factor: 4.244

7.  Ventral striatal dopamine release in response to smoking a regular vs a denicotinized cigarette.

Authors:  Arthur L Brody; Mark A Mandelkern; Richard E Olmstead; Zoe Allen-Martinez; David Scheibal; Anna L Abrams; Matthew R Costello; Judah Farahi; Sanjaya Saxena; John Monterosso; Edythe D London
Journal:  Neuropsychopharmacology       Date:  2008-06-18       Impact factor: 7.853

Review 8.  Clinical trials methods for evaluation of potential reduced exposure products.

Authors:  Dorothy K Hatsukami; Karen Hanson; Anna Briggs; Mark Parascandola; Jeanine M Genkinger; Richard O'Connor; Peter G Shields
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-12       Impact factor: 4.254

9.  Prolonged exposure to denicotinized cigarettes with or without transdermal nicotine.

Authors:  Eric C Donny; Melissa Jones
Journal:  Drug Alcohol Depend       Date:  2009-05-15       Impact factor: 4.492

Review 10.  Hormones, nicotine, and cocaine: clinical studies.

Authors:  Nancy K Mello
Journal:  Horm Behav       Date:  2009-10-14       Impact factor: 3.587

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.